Signs asset sale deal with Torrent Pharma
To sell brand regestrone including intellectual property right to TorrentUS FDA: Aurobindo Pharma's Hyderabad Unit 4 Issued Form 483 With 7 Observations
US FDA Observations For Aurobindo:
Buildings Used In Mfg Of A Drug Product Not Maintained In A Good StateLaurus Labs
Natco launches generic version of Sofosbuvir 400 mg/ Velpatasvir 100 mg in India, wherein the net profit of the sale of this Hepatitis C related product is
shared between Natco and LaurusTata Sponge
Environment Clearance Granted for Enhancement of DRI Production from 3,90,000 TPA to 4,25,000 TPAPunjab & Sind Bank
Allotment of Basel-III compliant Additional Tier-1 Bonds with coupon of 10.90 percent p.a. on Private Placement basisBharti Infratel Q4
Cons Net Profit At Rs 596.6 Cr Vs CNBC-TV18 Poll Of Rs 703 Cr
Cons EBITDA At Rs 1,585 Cr Vs CNBC-TV18 Poll Of Rs 1,563 Cr
For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory
To sell brand regestrone including intellectual property right to TorrentUS FDA: Aurobindo Pharma's Hyderabad Unit 4 Issued Form 483 With 7 Observations
US FDA Observations For Aurobindo:
Buildings Used In Mfg Of A Drug Product Not Maintained In A Good StateLaurus Labs
Natco launches generic version of Sofosbuvir 400 mg/ Velpatasvir 100 mg in India, wherein the net profit of the sale of this Hepatitis C related product is
shared between Natco and LaurusTata Sponge
Environment Clearance Granted for Enhancement of DRI Production from 3,90,000 TPA to 4,25,000 TPAPunjab & Sind Bank
Allotment of Basel-III compliant Additional Tier-1 Bonds with coupon of 10.90 percent p.a. on Private Placement basisBharti Infratel Q4
Cons Net Profit At Rs 596.6 Cr Vs CNBC-TV18 Poll Of Rs 703 Cr
Cons EBITDA At Rs 1,585 Cr Vs CNBC-TV18 Poll Of Rs 1,563 Cr
For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory
No comments:
Post a Comment